Please login to the form below
New Accounts, May, 2006 - Advertising
The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period February 2006 to April 2006 inclusive
The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period February 2006 to April 2006 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets.
To submit an entry for New Accounts, email new_accounts@pmlive.com
|
|
|
|
|
|
Actavis |
OTC products |
N/A |
Woolley Pau |
|
Actelion Pharmaceuticals |
Tracleer |
Cardiovascular |
Woolley Pau |
|
Altana Pharma |
Alvesco |
Respiratory |
pbc |
|
AstraZeneca |
Meronem |
Antibiotics |
GSW Worldwide |
|
Baxter |
Portfolio |
Haemophilia |
pbc |
|
Biogen Idec |
Tysabri |
Multiple sclerosis |
pbc |
|
Galen |
Regurin |
Overactive bladder |
Woolley Pau |
|
General Osteopathic Council |
Corporate |
Osteopathy |
Grey Healthcare |
|
Magister Consulting |
Nurse teams |
Corporate |
Life |
|
Menarini |
Migard |
Migraine |
pbc |
|
Nutricia Clinical Care |
Glutafin
|
Nutrition |
Life |
|
Pfizer (Europe/UK) |
Exubera |
Diabetes |
Grey Healthcare |
|
Pliva |
Cystistat |
Interstitial cystitis |
RFA Advertising & Marketing |
|
Recordati |
Zanidip |
Cardiology |
Affiniti (UK) |
|
Royal Numico (global) |
`Act Against Allergy' disease awareness |
Nutrition (milk allergy) |
Grey Healthcare |
|
Royal Numico (global) |
Fortimel |
Nutrition (sip feed) |
Grey Healthcare |
|
Royal Numico (global) |
Neocate |
Nutrition (baby formula) |
Grey Healthcare |
|
Schering AG |
Mirena |
Contraception |
Grey Healthcare |
Share
Related Hub content
Subscribe to our email news alerts
- New Playbook Alert: Virtual Patient Engagement
- AbbVie to expand solid tumour portfolio with $10bn ImmunoGen acquisition
- UK Biobank reveals new data from world's largest genetic project
- New study finds dose of Mavenclad treatment could predict MS relapse risk
- Astellas shares positive 24-week results for non-hormonal menopause drug fezolinetant
- GSK global survey reveals misunderstandings about shingles in adults
No results were found
PMHub
Life Healthcare Communications
Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...
Latest intelligence
- New Playbook Alert: Virtual Patient Engagement
- ...
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
- The problem with clinical trials (and how virtual insight-gathering can help)
- While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
